Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humica Weihai is a biotechnology firm based in Weihai, China, that specializes in the research, development, and large-scale production of humic acid and fulvic acid derivatives. The company provides high-purity, pharmaceutical-grade ingredients used in the treatment of inflammatory conditions, gastrointestinal diseases, and skin disorders. Their product portfolio includes sodium humate and fulvic acid powders and liquids, which are manufactured under strict quality control standards for the global healthcare and veterinary markets. Humica Weihai is recognized for its expertise in mineral-source extraction technology, positioning itself as a key supplier for the nutraceutical and pharmaceutical industries. The company's operations span from raw material sourcing to advanced purification and international distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HUMICA WEIHAI INTERNATIONAL.